Related Experiment Video
Updated: Jun 25, 2026

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
CBCRisk-Mastectomy: A Prediction Tool to Aid Contralateral Prophylactic Mastectomy Decision-Making
Ibrahim H Sajal1, Ruth M Pfeiffer2, Ismail Jatoi3
1Department of Mathematical Sciences, University of Texas at Dallas, Richardson, Texas.
A new model, CBCRisk-Mastectomy, predicts contralateral breast cancer (CBC) risk in mastectomy patients. This tool aids informed decisions about contralateral prophylactic mastectomy (CPM) for women with unilateral breast cancer (BC).
Area of Science:
- Oncology
- Biostatistics
- Epidemiology
Background:
- Unilateral breast cancer (BC) patients often opt for contralateral prophylactic mastectomy (CPM) despite decreasing contralateral breast cancer (CBC) risk.
- Risk prediction models can support informed decisions regarding CPM.
Purpose of the Study:
- To develop and validate CBCRisk-Mastectomy, a risk prediction model specifically for BC patients undergoing mastectomy.
- To improve decision-making for CPM in BC patients.
Main Methods:
- Utilized data from the Breast Cancer Surveillance Consortium (BCSC) and SEER cancer registry.
- Employed conditional logistic regression models trained on 2660 BC patients (665 CBC cases) from BCSC.
- Integrated SEER data for absolute risk estimation and cross-validation for internal validation and comparison with CBCRisk.
Main Results:
- CBCRisk-Mastectomy incorporates nine predictors: first BC type, lobular carcinoma in situ status, estrogen receptor status, tumor stage, breast density, age at BC diagnosis, family history of BC, age at first birth, and body mass index.
- Achieved a higher area under the curve (0.62) for five-year CBC risk prediction compared to the existing CBCRisk model (0.58).
Conclusions:
- CBCRisk-Mastectomy offers a valuable tool for clinicians counseling BC patients scheduled for mastectomy.
- The model can enhance informed decision-making regarding CPM by providing personalized risk assessments.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Cancer Survival Analysis
Relative Risk